These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 12828485)

  • 21. Occurrence of psilocybin and psilocin in Psilocybe pseudobullacea (Petch) Pegler from the Venezuelan Andes.
    Marcano V; Morales Méndez A; Castellano F; Salazar FJ; Martinez L
    J Ethnopharmacol; 1994 Jul; 43(2):157-9. PubMed ID: 7967656
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Occurrence of psilocin in Psilocybe baeocystis.
    BENEDICT RG; BRADY LR; TYLER VE
    J Pharm Sci; 1962 Apr; 51():393-4. PubMed ID: 13867140
    [No Abstract]   [Full Text] [Related]  

  • 23. [Psilocybin - public available psychodysleptic].
    Dydak K; Śliwińska-Mossoń M; Milnerowicz H
    Postepy Hig Med Dosw (Online); 2015 Sep; 69():986-95. PubMed ID: 26400885
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of psilocybin and psilocin in Psilocybe subcubensis Guzmán by ion mobility spectrometry and gas chromatography-mass spectrometry.
    Keller T; Schneider A; Regenscheit P; Dirnhofer R; Rücker T; Jaspers J; Kisser W
    Forensic Sci Int; 1999 Jan; 99(2):93-105. PubMed ID: 10077856
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Research on acute toxicity and the behavioral effects of methanolic extract from psilocybin mushrooms and psilocin in mice.
    Zhuk O; Jasicka-Misiak I; Poliwoda A; Kazakova A; Godovan VV; Halama M; Wieczorek PP
    Toxins (Basel); 2015 Mar; 7(4):1018-29. PubMed ID: 25826052
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Studies on hallucinogens. 3. Synthesis of psilocin (author's transl)].
    Ono M; Shimamine M; Takahashi K
    Eisei Shikenjo Hokoku; 1973; 91(0):39-41. PubMed ID: 4800137
    [No Abstract]   [Full Text] [Related]  

  • 27. The effect of Psilocybe cubensis extract on hippocampal neurons in vitro.
    Moldavan MG; Grodzinskaya AA; Solomko EF; Lomberh ML; Wasser SP; Storozhuk VM
    Fiziol Zh (1994); 2001; 47(6):15-23. PubMed ID: 11962085
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Magic mushroom compound is a potential treatment for patients with major depression.
    Nurs Stand; 2016 Jun; 30(41):15. PubMed ID: 27286599
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Discrimination of psychoactive fungi (commonly called "magic mushrooms") based on the DNA sequence of the internal transcribed spacer region].
    Maruyama T; Shirota O; Kawahara N; Yokoyama K; Makino Y; Goda Y
    Shokuhin Eiseigaku Zasshi; 2003 Feb; 44(1):44-8. PubMed ID: 12749196
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chemoenzymatic Synthesis of 5-Methylpsilocybin: A Tryptamine with Potential Psychedelic Activity.
    Fricke J; Sherwood AM; Halberstadt AL; Kargbo RB; Hoffmeister D
    J Nat Prod; 2021 Apr; 84(4):1403-1408. PubMed ID: 33667102
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of psilocin and psilocybin on human 5-HT
    Neumann J; Dimov K; Azatsian K; Hofmann B; Gergs U
    Toxicol Lett; 2024 Jul; 398():55-64. PubMed ID: 38876450
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The molecular basis of the antidepressant action of the magic mushroom extract, psilocin.
    Hakami Zanjani AA; Nguyen TQT; Jacobsen L; Khandelia H
    Biochim Biophys Acta Proteins Proteom; 2023 Jul; 1871(4):140914. PubMed ID: 37019325
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chemistry and Toxicology of Major Bioactive Substances in
    Patocka J; Wu R; Nepovimova E; Valis M; Wu W; Kuca K
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33672330
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Studies on psilocybin, a hallucinogenic drug from the Mexican mushroom Psilocybe mexicana].
    GNIRSS F
    Schweiz Arch Neurol Neurochir Psychiatr; 1959; 84():346-8. PubMed ID: 13850311
    [No Abstract]   [Full Text] [Related]  

  • 35. Synthetic studies of psilocin analogs having either a formyl group or bromine atom at the 5- or 7-position.
    Yamada F; Tamura M; Hasegawa A; Somei M
    Chem Pharm Bull (Tokyo); 2002 Jan; 50(1):92-9. PubMed ID: 11824592
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Forensic analysis of hallucinogenic mushrooms and khat (Catha edulis Forsk) using cation-exchange liquid chromatography.
    Laussmann T; Meier-Giebing S
    Forensic Sci Int; 2010 Feb; 195(1-3):160-4. PubMed ID: 20047807
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neurovascular and neuroimaging effects of the hallucinogenic serotonin receptor agonist psilocin in the rat brain.
    Spain A; Howarth C; Khrapitchev AA; Sharp T; Sibson NR; Martin C
    Neuropharmacology; 2015 Dec; 99():210-20. PubMed ID: 26192543
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Determination of psilocybin and psilocin content in multiple Psilocybe cubensis mushroom strains using liquid chromatography - tandem mass spectrometry.
    Goff R; Smith M; Islam S; Sisley S; Ferguson J; Kuzdzal S; Badal S; Kumar AB; Sreenivasan U; Schug KA
    Anal Chim Acta; 2024 Feb; 1288():342161. PubMed ID: 38220293
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An aqueous-organic extraction method for the isolation and identification of psilocin from hallucinogenic mushrooms.
    Casale JF
    J Forensic Sci; 1985 Jan; 30(1):247-50. PubMed ID: 4038992
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phylogenetic relationship of psychoactive fungi based on rRNA gene for a large subunit and their identification using the TaqMan assay (II).
    Maruyama T; Kawahara N; Yokoyama K; Makino Y; Fukiharu T; Goda Y
    Forensic Sci Int; 2006 Nov; 163(1-2):51-8. PubMed ID: 16343833
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.